A5016767245- Tuberculosis Research and Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Pediatric health and respiratory diseases
- Mycobacterium research and diagnosis
- Infectious Diseases and Tuberculosis
- Medical and Biological Ozone Research
- Spaceflight effects on biology
- Cytokine Signaling Pathways and Interactions
- Human Health and Disease
- Nanoparticles: synthesis and applications
- Immunodeficiency and Autoimmune Disorders
- Pediatric Urology and Nephrology Studies
- Diagnosis and treatment of tuberculosis
- Pharmacological Effects of Natural Compounds
- Diverse Scientific Research in Ukraine
- Clostridium difficile and Clostridium perfringens research
- Hydrogen's biological and therapeutic effects
- Urinary Tract Infections Management
- Agriculture and Biological Studies
- Blood groups and transfusion
- Synthesis and biological activity
- Microplastics and Plastic Pollution
- Material Properties and Applications
- Kidney Stones and Urolithiasis Treatments
- Vitamin D Research Studies
Danylo Halytsky Lviv National Medical University
2018-2024
Анотація. Вивчення біоцидної ефективності фарби водоемульсійної «Снєжка Платініум Кітчен-Бас» проводили відповідно до ДСТУ ЕN 15457:2015. У випробуванні використали музейні штами грибів Aspergillus niger F-16693 та Chaetomium globosum F-405, тверді селективні середовища Чапека-Докса Сабуро, основа під фарбу - диски фільтрувального паперу. Дослідження показали, що тестова покрита плівкою упродовж 21 дня, нормований термін інкубації, при температурі +25○С, вологості 85 %проявляла високу...
The aim of the study - to feasibility using natural immunomodulator BIVEL (conditionally called BI-V) as a nonspecific immunoprevention tuberculosis (TB) among contacted children from focies chemodrug-resistant infection on basis clinical and immunological researches. Research metods. object was 120 multidrug-resistant (FsMDR-TBI) including 75 45 adolescents. first contact group included 95 children/adolescents who did not receive BI-V second one ‒ 25 infected received BI-V. Immunological...
Objective — is to establish violations in the immune system that aggravate course and reduce effectiveness of treatment patients with multidrugresistant pulmonary tuberculosis.Materials methods. A comparative analysis nonspecific systemic cellular response at link was performed 44 a newly diagnosed destructive tuberculosis (NDD MDR-TB) effective, not very effective ineffective antimycobacterial therapy (AMBT).Results discussion. In NDD MDR-TB inefficient therapy, compared treated...
BACKGROUND. Research results in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB) the dynamics of treatment. OBJECTIVE. To study main causes chemotherapy inefficiency MDR-TB. MATERIALS AND METHODS. Comprehensive examination 176 MDR-TB, which was divided into two groups: new cases disease (95 patients) and repeated (81 patients). RESULTS. The has shown that following prognostic criteria are at high risk for development MDR-TB: history anti-tuberculosis treatment, common...
РезюмеЦель исследования: изучить целесообразность назначения иммуномодулятора мурамилпептидного ряда у больных мультирезистентным туберкулезом (МРТБ) на основании клинических, рентгенотомографических и общепринятых лабораторных исследований.Материалы методы.Обследовано 47 больных.В качестве патогенетического препарата был использован иммуномодулятор ряда.Больные были распределены две группы: 1 группу составили 22 пациента, которые получали только противотуберкулезные препараты (ПТП); 2 -25...
Objective — to investigate immuno-metabolic homeostasis in patients with new and recurrent cases of destructive forms multidrug-resistant pulmonary tuberculosis (MDR-PTB) after treatment bedaquiline linezolid. Materials methods. A clinical laboratory examination 175 people MDR-PTB (89 86 MDR-PTB). The study was performed before total leukocytes count (L), the leukocyte differential (leukocyte formula), determined all subjects, content populations subpopulations lymphocytes were calculated...
Introduction. Against the backdrop of multiple and widespread drug resistance Mycobacterium tuberculosis (MDR-TB), there has been a significant decline in effectiveness treatment (TB) patients Ukraine globally. Therefore, recent years, new antimycobacterial drugs, such as bedaquiline (Bdq), delamanid (Dlm) pretomanid, have introduced to improve efficacy adults, children adolescents. The purpose - study complex with (Bdq) under 18 years old extensively drug-resistant pulmonary TB...
BACKGROUND. The feasibility of combining antimycobacterial therapy (AMBT) with bedaquiline (Bdq) and delamanid (Dlm) non-specific immunomodulator BI-V in children adolescents multidrug-resistant rifampicin-resistant pulmonary tuberculosis (MDR/Rif-TBP) needs to be studied.
 OBJECTIVE. To find out the effectiveness use complex AMBT Bdq Dlm MDR/Rif-TBP.
 MATERIALS AND METHODS. Children MDR/Rif-TBP at initial stage were given (BIVEL, Slovenia) as a immunomodulator. patients divided...
Immunological methods are important for diagnosing tuberculosis, evaluating the process activity, and forecasting course of disease recovery.
 Materials methods. 47 patients with first diagnosed destructive sputum smear-positive pulmonary tuberculosis underwent a complex immunoassay. The were divided into two groups based on sensitivity/resistance mycobacterium to antimycobacterial agents. group consisted 22 first-diagnosed chemosensitive preserved sensitivity second 25 multi-drug...
Nitroxoline is a synthetic uroantiseptic, effective against wide range of gram-positive, gram-negative bacteria and fungi. For long time it has been used for the treatment prevention acute, chronic recurrent urinary tract infections, because to this day retains high activity family Enterobacteriaceae. With increasing resistance uropathogens new antimicrobial drugs, may be an alternative drug acute uncomplicated infections. The results scientific research on importance as first-line in...
завідуюча лабораторії молекулярно-генетичних досліджень, Львівський національний медичний університет імені Данила Галицького
OBJECTIVE. Evaluating according to laboratory tests the effectiveness of Liasten in treatment patients with multidrug-resistant pulmonary tuberculosis (MDR-TB).
 MATERIALS AND METHODS. Evaluation etiotropic and etiopathogenetic therapy 57 MDR-TB was performed. According schemes, were divided into groups. The control group (n=22) received individualized antimycobacterial (AMBT) regimens. experimental (n=35) AMBT combination Liasten. regimens performed on basis indicators general clinical...